Anita I. Kapanen

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 656 citations

Intestinal Type, Oncology, Gastrointestinal Oncology +11

Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

Péter Nagy, Elza Friedländer, Minna Tanner et al. · Cancer Research · 2005 · 509 citations · Full text

Erbb2 Gene Amplification, Breast Oncology, G Protein-coupled Receptor +13

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

Minna Tanner, Anita I. Kapanen, Teemu T. Junttila et al. · Molecular Cancer Therapeutics · 2004 · 267 citations · Full text

Tumor Biology, Breast Oncology, Novel Cell Line +13

Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture

Qiang Qu, M. Perälä-Heape, Anita I. Kapanen et al. · Bone · 1998 · 246 citations

Developmental Biology, Bone Morphogenic Protein, Bone Repair +8

Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance

Márk Barok, Jorma Isola, Zsuzsanna Pályi‐Krekk et al. · Molecular Cancer Therapeutics · 2007 · 235 citations · Full text